BioCentury | Oct 1, 2018
Company News

Pfizer COO Bourla to succeed Read as CEO

...of the pharma's injectables business with the successful acquisition of Hospira Inc. in 2015 and InnoPharma Inc....
BioCentury | Oct 20, 2017
Company News

Allergan insists deal with tribe is not a sham

...market a generic version of Restasis. InnoPharma was acquired by Pfizer Inc. (NYSE:PFE) in 2014. InnoPharma...
...or earlier "under certain circumstances." Allergan also said that "under certain circumstances," Allergan will supply InnoPharma...
BioCentury | Oct 13, 2017
Company News

Allergan insists deal with tribe is not a sham

...market a generic version of Restasis. InnoPharma was acquired by Pfizer Inc. (NYSE:PFE) in 2014. InnoPharma...
...or earlier "under certain circumstances." Allergan also said that "under certain circumstances," Allergan will supply InnoPharma...
BioCentury | Nov 9, 2015
Strategy

Pfizer's growth spurt

...million in cash. InnoPharma is eligible for up to $135 million in milestones. Sales for InnoPharma...
BioCentury | Oct 13, 2014
Company News

InnoPharma, Pfizer deal

...InnoPharma is also eligible for up to $135 million in milestones (see BioCentury, July 21). InnoPharma Inc....
BioCentury | Jul 21, 2014
Company News

Pfizer, InnoPharma deal

...in cash up front. InnoPharma is also eligible for up to $135 million in milestones. InnoPharma...
...73 products. The company’s injectables portfolio is part of its Global Established Pharma business. The InnoPharma...
...Pfizer. JPMorgan was financial advisor and Morgan, Lewis & Bockius LLP was legal advisor to InnoPharma...
BioCentury | Jul 17, 2014
Company News

Pfizer to acquire sterile injectable company InnoPharma

...in cash up front. InnoPharma is also eligible for up to $135 million in milestones. InnoPharma...
...company was bidding to acquire AstraZeneca plc (LSE:AZN; NYSE:AZN) (see BioCentury, May 12) . The InnoPharma...
BioCentury | Nov 18, 2013
Financial News

InnoPharma financial update

...InnoPharma secured a $20 million term loan facility from Athyrium Capital Management. InnoPharma Inc. , Piscataway, N.J...
BioCentury | Jan 14, 2013
Company News

Cumberland, Fresenius, InnoPharma, Perrigo Co. sales and marketing update

...of the approval, InnoPharma received 180-day exclusivity for the generic. Fresenius Kabi has rights from InnoPharma...
...Pharmaceuticals Inc. (NASDAQ:CPIX), Nashville, Tenn. Fresenius SE & Co. KGaA (Xetra:FRE; OTCBB:FSNUY), Bad Homburg, Germany InnoPharma Inc....
BioCentury | Jun 11, 2012
Financial News

InnoPharma completes venture financing

InnoPharma Inc. , Piscataway, N.J. Business: Cancer, Drug delivery, Generics Date completed: 6/7/12 Type: Venture financing Raised: $8 million Investors: Comerica Bank; NXT Capital Venture Finance WIR Staff cancer...
Items per page:
1 - 10 of 14
BioCentury | Oct 1, 2018
Company News

Pfizer COO Bourla to succeed Read as CEO

...of the pharma's injectables business with the successful acquisition of Hospira Inc. in 2015 and InnoPharma Inc....
BioCentury | Oct 20, 2017
Company News

Allergan insists deal with tribe is not a sham

...market a generic version of Restasis. InnoPharma was acquired by Pfizer Inc. (NYSE:PFE) in 2014. InnoPharma...
...or earlier "under certain circumstances." Allergan also said that "under certain circumstances," Allergan will supply InnoPharma...
BioCentury | Oct 13, 2017
Company News

Allergan insists deal with tribe is not a sham

...market a generic version of Restasis. InnoPharma was acquired by Pfizer Inc. (NYSE:PFE) in 2014. InnoPharma...
...or earlier "under certain circumstances." Allergan also said that "under certain circumstances," Allergan will supply InnoPharma...
BioCentury | Nov 9, 2015
Strategy

Pfizer's growth spurt

...million in cash. InnoPharma is eligible for up to $135 million in milestones. Sales for InnoPharma...
BioCentury | Oct 13, 2014
Company News

InnoPharma, Pfizer deal

...InnoPharma is also eligible for up to $135 million in milestones (see BioCentury, July 21). InnoPharma Inc....
BioCentury | Jul 21, 2014
Company News

Pfizer, InnoPharma deal

...in cash up front. InnoPharma is also eligible for up to $135 million in milestones. InnoPharma...
...73 products. The company’s injectables portfolio is part of its Global Established Pharma business. The InnoPharma...
...Pfizer. JPMorgan was financial advisor and Morgan, Lewis & Bockius LLP was legal advisor to InnoPharma...
BioCentury | Jul 17, 2014
Company News

Pfizer to acquire sterile injectable company InnoPharma

...in cash up front. InnoPharma is also eligible for up to $135 million in milestones. InnoPharma...
...company was bidding to acquire AstraZeneca plc (LSE:AZN; NYSE:AZN) (see BioCentury, May 12) . The InnoPharma...
BioCentury | Nov 18, 2013
Financial News

InnoPharma financial update

...InnoPharma secured a $20 million term loan facility from Athyrium Capital Management. InnoPharma Inc. , Piscataway, N.J...
BioCentury | Jan 14, 2013
Company News

Cumberland, Fresenius, InnoPharma, Perrigo Co. sales and marketing update

...of the approval, InnoPharma received 180-day exclusivity for the generic. Fresenius Kabi has rights from InnoPharma...
...Pharmaceuticals Inc. (NASDAQ:CPIX), Nashville, Tenn. Fresenius SE & Co. KGaA (Xetra:FRE; OTCBB:FSNUY), Bad Homburg, Germany InnoPharma Inc....
BioCentury | Jun 11, 2012
Financial News

InnoPharma completes venture financing

InnoPharma Inc. , Piscataway, N.J. Business: Cancer, Drug delivery, Generics Date completed: 6/7/12 Type: Venture financing Raised: $8 million Investors: Comerica Bank; NXT Capital Venture Finance WIR Staff cancer...
Items per page:
1 - 10 of 14